If you made any changes in Pure, your changes will be visible here soon.

Research Output 2013 2019

  • 440 Citations
  • 12 h-Index
  • 25 Article
  • 5 Letter
  • 1 Editorial
  • 1 Review article
Filter
Article
2019
1 Citation (Scopus)

Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model

Çağlayan, Ç., Terawaki, H., Ayer, T., Goldstein, J. S., Rai, A., Chen, Q. & Flowers, C., May 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 5, p. 300-309.e5

Research output: Contribution to journalArticle

Follicular Lymphoma
Survival
Therapeutics
Confidence Intervals
Vincristine
1 Citation (Scopus)

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan

Chhatwal, J., Chen, Q., Wang, X., Ayer, T., Zhuo, Y., Janjua, N. Z. & Kanwal, F., May 3 2019, In : JAMA network open. 2, 5, p. e193613

Research output: Contribution to journalArticle

Open Access
Pakistan
Hepatitis C
Hepacivirus
Costs and Cost Analysis
Virus Diseases
1 Citation (Scopus)

Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: A modelling study

Chen, Q., Ayer, T., Bethea, E., Kanwal, F., Wang, X., Roberts, M., Zhuo, Y., Fagiuoli, S., Petersen, J. & Chhatwal, J., Jun 1 2019, In : BMJ open. 9, 6, e026726.

Research output: Contribution to journalArticle

Open Access
Hepatitis C
Antiviral Agents
Hepacivirus
Therapeutics
Spain

Dual-mode inventory management under a chance credit constraint

Chen, Q., Zhao, L., Fransoo, J. C. & Li, Z., Mar 11 2019, In : OR Spectrum. 41, 1, p. 147-178 32 p.

Research output: Contribution to journalArticle

Inventory management
Credit constraints
Lead time
Inventory policy
Working capital
32 Citations (Scopus)

Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States

Chen, Q., Larochelle, M. R., Weaver, D. T., Lietz, A. P., Mueller, P. P., Mercaldo, S., Wakeman, S. E., Freedberg, K. A., Raphel, T. J., Knudsen, A. B., Pandharipande, P. V. & Chhatwal, J., Feb 1 2019, In : JAMA network open. 2, 2, p. e187621

Research output: Contribution to journalArticle

Open Access
Opioid Analgesics
Prescriptions
Uncertainty
Incidence
Centers for Disease Control and Prevention (U.S.)

The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States

Chhatwal, J., Chen, Q., Bethea, E. D., Hur, C., Spaulding, A. C. & Kanwal, F., Jul 2019, In : Alimentary Pharmacology and Therapeutics. 50, 1, p. 66-74 9 p.

Research output: Contribution to journalArticle

Hepatitis C
Hepacivirus
Incidence
Medicaid
Medicare
2018
4 Citations (Scopus)
Hepatitis C
Cost-Benefit Analysis
Antiviral Agents
Genotype
Costs and Cost Analysis
4 Citations (Scopus)

Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma

Chen, Q., Staton, A. D., Ayer, T., Goldstein, D. A., Koff, J. L. & Flowers, C. R., Jul 3 2018, In : Leukemia and Lymphoma. 59, 7, p. 1700-1709 10 p.

Research output: Contribution to journalArticle

Precision Medicine
Lymphoma, Large B-Cell, Diffuse
Vincristine
Prednisone
Doxorubicin
15 Citations (Scopus)

Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA

Chhatwal, J., Chen, Q., Ayer, T., Bethea, E. D., Kanwal, F., Kowdley, K. V., Wang, X., Roberts, M. S. & Gordon, S. C., Apr 2018, In : Alimentary Pharmacology and Therapeutics. 47, 7, p. 1023-1031 9 p.

Research output: Contribution to journalArticle

Open Access
Hepacivirus
Antiviral Agents
Therapeutics
Fibrosis
Viremia
1 Citation (Scopus)

Microsimulation Modeling in Oncology

Çağlayan, Ç., Terawaki, H., Chen, Q., Rai, A., Ayer, T. & Flowers, C. R., Dec 1 2018, In : JCO clinical cancer informatics. 2, p. 1-11 11 p.

Research output: Contribution to journalArticle

Medicine
Medical Subject Headings
Precision Medicine
Sample Size
Population

Optimal M-switch surveillance policies for liver cancer in a hepatitis C-infected population

Chen, Q., Ayer, T. & Chhatwal, J., May 1 2018, In : Operations Research. 66, 3, p. 673-696 24 p.

Research output: Contribution to journalArticle

Integer programming
Liver
Switches
Cost effectiveness
Viruses
19 Citations (Scopus)

Should we treat acute hepatitis C? A decision and cost-effectiveness analysis

Bethea, E. D., Chen, Q., Hur, C., Chung, R. T. & Chhatwal, J., Mar 2018, In : Hepatology. 67, 3, p. 837-846 10 p.

Research output: Contribution to journalArticle

Hepatitis C
Hepacivirus
Cost-Benefit Analysis
Quality-Adjusted Life Years
Costs and Cost Analysis
2017
5 Citations (Scopus)

Bevacizumab for metastatic colorectal cancer: A global cost-effectiveness analysis

Goldstein, D. A., Chen, Q., Ayer, T., Chan, K. K. W., Virik, K., Hammerman, A., Brenner, B., Flowers, C. R. & Hall, P. S., Jun 2017, In : Oncologist. 22, 6, p. 694-699 6 p.

Research output: Contribution to journalArticle

Open Access
Quality-Adjusted Life Years
Cost-Benefit Analysis
Colorectal Neoplasms
Costs and Cost Analysis
Israel
37 Citations (Scopus)

Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India

Aggarwal, R., Chen, Q., Goel, A., Seguy, N., Pendse, R., Ayer, T. & Chhatwal, J., May 2017, In : PloS one. 12, 5, e0176503.

Research output: Contribution to journalArticle

Open Access
hepatitis C
Hepatitis C virus
cost effectiveness
Hepatitis C
Cost effectiveness
33 Citations (Scopus)

Cost-effectiveness of immune checkpoint inhibition in BRAF wild-type advanced melanoma

Kohn, C. G., Zeichner, S. B., Chen, Q., Montero, A. J., Goldstein, D. A. & Flowers, C. R., Apr 10 2017, In : Journal of Clinical Oncology. 35, 11, p. 1194-1202 9 p.

Research output: Contribution to journalArticle

Cost-Benefit Analysis
Melanoma
Quality-Adjusted Life Years
Dacarbazine
Therapeutics
57 Citations (Scopus)

Economic burden of chronic lymphocytic leukemia in the era of oral targeted therapies in the United States

Chen, Q., Jain, N., Ayer, T., Wierda, W. G., Flowers, C. R., O'Brien, S. M., Keating, M. J., Kantarjian, H. M. & Chhatwal, J., Jan 10 2017, In : Journal of Clinical Oncology. 35, 2, p. 166-174 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Economics
Costs and Cost Analysis
Therapeutics
Standard of Care
2016
5 Citations (Scopus)

Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma

Chen, Q., Ayer, T., Nastoupil, L. J., Koff, J. L., Staton, A. D., Chhatwal, J. & Flowers, C. R., Apr 2 2016, In : Leukemia and Lymphoma. 57, 4, p. 842-851 10 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
African Americans
Population
Logistic Models
Survival
6 Citations (Scopus)

Sensitivity Analysis in Sequential Decision Models

Chen, Q., Ayer, T. & Chhatwal, J., Jan 1 2016, In : Medical Decision Making. 37, 2, p. 243-252 10 p.

Research output: Contribution to journalArticle

Markov Chains
Uncertainty
Cost-Benefit Analysis
Decision Support Techniques
Joints
2015
16 Citations (Scopus)

Comparing the cost-effectiveness of rituximab maintenance and radioimmunotherapy consolidation versus observation following first-line therapy in patients with follicular lymphoma

Chen, Q., Ayer, T., Nastoupil, L. J., Rose, A. C. & Flowers, C. R., Mar 1 2015, In : Value in Health. 18, 2, p. 189-197 9 p.

Research output: Contribution to journalArticle

Open Access
Radioimmunotherapy
Follicular Lymphoma
Cost-Benefit Analysis
Maintenance
Observation
46 Citations (Scopus)

Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer

Goldstein, D. A., Ahmad, B. B., Chen, Q., Ayer, T., Howard, D. H., Lipscomb, J., El-Rayes, B. F. & Flowers, C. R., Nov 10 2015, In : Journal of Clinical Oncology. 33, 32, p. 3727-3732 6 p.

Research output: Contribution to journalArticle

Cost-Benefit Analysis
Colorectal Neoplasms
Quality-Adjusted Life Years
Costs and Cost Analysis
Placebos
71 Citations (Scopus)

First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer:A United States-based cost-effectiveness analysis

Goldstein, D. A., Chen, Q., Ayer, T., Howard, D. H., Lipscomb, J., El-Rayes, B. F. & Flowers, C. R., Apr 1 2015, In : Journal of Clinical Oncology. 33, 10, p. 1112-1118 7 p.

Research output: Contribution to journalArticle

Cost-Benefit Analysis
Colorectal Neoplasms
Quality-Adjusted Life Years
Drug Therapy
Fluorouracil
30 Citations (Scopus)

Necitumumab in metastatic squamous cell lung cancer

Goldstein, D. A., Chen, Q., Ayer, T., Howard, D. H., Lipscomb, J., Ramalingam, S. S., Khuri, F. R. & Flowers, C. R., Dec 2015, In : JAMA Oncology. 1, 9, p. 1293-1300 8 p.

Research output: Contribution to journalArticle

Open Access
Squamous Cell Neoplasms
Lung Neoplasms
Costs and Cost Analysis
gemcitabine
Drug Costs
1 Citation (Scopus)

Next-generation prognostic assessment for diffuse large B-cell lymphoma

Staton, A. D., Koff, J. L., Chen, Q., Ayer, T. & Flowers, C. R., Sep 1 2015, In : Future Oncology. 11, 17, p. 2443-2457 15 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Epidemiologic Factors
Salvage Therapy
Therapeutics
Standard of Care
2014
15 Citations (Scopus)

Cost effectiveness analysis of pharmacokinetically-guided 5-fluorouracil in folfox chemotherapy for metastatic colorectal cancer

Goldstein, D. A., Chen, Q., Ayer, T., Howard, D. H., Lipscomb, J., Harvey, R. D., El-Rayes, B. F. & Flowers, C. R., Jan 1 2014, In : Clinical Colorectal Cancer. 13, 4, p. 219-225 7 p.

Research output: Contribution to journalArticle

Body Surface Area
Fluorouracil
Cost-Benefit Analysis
Quality-Adjusted Life Years
Colorectal Neoplasms
2013
18 Citations (Scopus)

Artificial neural networks in mammography interpretation and diagnostic decision making

Ayer, T., Chen, Q. & Burnside, E. S., Jul 1 2013, In : Computational and Mathematical Methods in Medicine. 2013, 832509.

Research output: Contribution to journalArticle

Open Access
Mammography
Artificial Neural Network
Diagnostics
Decision Making
Decision making